Several cohort studies conducted in Asia, Europe and the Americas have evaluated the clinical significance of antineutrophil cytoplasmic antibodies (ANCA) when detected in patients with interstitial lung disease (ILD) as well as the types of ILD encountered in patients with microscopic polyangiitis (MPA) and their effect on the prognosis of MPA.
Read Article
“Ulrich Specks, M.D. is Professor of Medicine, Mayo Clinic College of Medicine & Science and a Consultant in the Division of Pulmonary & Critical Care Medicine at Mayo Clinic Rochester, MN. He has had a career-long clinical practice focus on antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis as well as interstitial lung disease. Dr. Specks' research focusing primarily on ANCA-associated vasculitis ranges from laboratory-based studies on mechanisms of disease to clinical trials.”
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
